OPKO Health Inc. is a high-risk pharmaceutical company based in the United States. Specializing in biotechnology, OPKO Health operates programs in pharmaceutical and diagnostic development. The company's ESG score is 33.5, reflecting its commitment to environmental sustainability and governance. With a core genetic testing operation in diagnostics and a commercial supply pharmaceutical company in pharmaceuticals, OPKO Health is a diversified player in the industry. Additionally, OPKO Health has a world supply-chain operation in Ireland and owns a specialty active pharmaceutical ingredients manufacturer in Israel. Operating in two distinct segments, Diagnostics and Pharmaceuticals, OPKO Health Inc. offers a wide range of healthcare solutions.